Cargando…

Ivabradine Prevents Heart Rate Acceleration in Patients with Chronic Obstructive Pulmonary Disease and Coronary Heart Disease after Salbutamol Inhalation

Accelerated sinus rhythm is an important side effect of inhaled salbutamol which is especially harmful in patients with chronic obstructive pulmonary disease (COPD) and coronary heart disease (CHD). Cross-over, randomized, open label study design. 20 patients (18 males and two females) with COPD sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zulkarneev, Rustem, Zagidullin, Naufal, Abdrahmanova, Guzel, Hoppe, Uta C., Zagidullin, Shamil
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2012
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3763641/ https://www.ncbi.nlm.nih.gov/pubmed/24281409 http://dx.doi.org/10.3390/ph5040398

Ejemplares similares

The Impact of Remote Ischemic Preconditioning on Arterial Stiffness and Heart Rate Variability in Patients with Angina Pectoris
por: Zagidullin, Naufal, et al.
Publicado: (2016)

Editorial: Cardio-Protection and Heart Repair: New Drugs, Targets and Approaches
por: Zagidullin, Naufal, et al.
Publicado: (2021)

Combining Novel Biomarkers for Risk Stratification of Two-Year Cardiovascular Mortality in Patients with ST-Elevation Myocardial Infarction
por: Zagidullin, Naufal, et al.
Publicado: (2020)

Short-Term Effect of Inhaled Salbutamol on Heart Rate in Healthy Volunteers
por: Syed, Salman A, et al.
Publicado: (2021)

Ivabradine, coronary artery disease, and heart failure: beyond rhythm control
por: Scicchitano, Pietro, et al.
Publicado: (2014)

The Acute Effects of the Use of Salbutamol and Ipratropium on the Heart Rates of Patients With Obstructive Airway Disease
por: Akhtar, Ayesha, et al.
Publicado: (2023)

Cardiovascular Biomarkers for Prediction of in-hospital and 1-Year Post-discharge Mortality in Patients With COVID-19 Pneumonia
por: Motloch, Lukas J., et al.
Publicado: (2022)

Ivabradine in Cardiovascular Disease: Heart Rate Isn't Everything
por: Feldman, Arthur M.
Publicado: (2015)

Ivabradine: An Intelligent Drug for the Treatment of Ischemic Heart Disease
por: Riccioni, Graziano
Publicado: (2012)

Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018)

Cyclin L1 controls cardiomyocyte proliferation and heart repair after injury
por: Gong, Rui, et al.
Publicado: (2023)

Pathophysiology of Calcium Mediated Ventricular Arrhythmias and Novel Therapeutic Options with Focus on Gene Therapy
por: Paar, Vera, et al.
Publicado: (2019)

Selective and Specific Inhibition of I(f) with Ivabradine for the Treatment of Coronary Artery Disease or Heart Failure
por: Deedwania, Prakash
Publicado: (2013)

Regulation of cardiomyocyte fate plasticity: a key strategy for cardiac regeneration
por: Gong, Rui, et al.
Publicado: (2021)

Advances in the management of heart failure: the role of ivabradine
por: Müller-Werdan, Ursula, et al.
Publicado: (2016)

Heart Rate Reduction by Ivabradine: Slowly but Surely?
por: Kojonazarov, Baktybek
Publicado: (2020)

Ivabradine and Bisoprolol on Doppler-derived Coronary Flow Velocity Reserve in Patients with Stable Coronary Artery Disease: Beyond the Heart Rate
por: Tagliamonte, Ercole, et al.
Publicado: (2015)

Effect of ivabradine-induced heart rate reduction on flow-mediated dilation measured with high-sensitivity ultrasound in patients with stable coronary heart disease
por: Jochmann, Nicoline, et al.
Publicado: (2014)

An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation
por: Zhang, Xuemei, et al.
Publicado: (2014)

Short-Term Effects of Ivabradine in Patients with Chronic Stable Ischemic Heart Disease
por: Zaky, Hosam, et al.
Publicado: (2013)

Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure
por: Rohm, Ilonka, et al.
Publicado: (2016)

Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
por: Kansal, Anuraag R., et al.
Publicado: (2016)

Ivabradine in Congestive Heart Failure: Patient Selection and Perspectives
por: Sattar, Yasar, et al.
Publicado: (2019)

Accidental Cutaneous Burns Secondary to Salbutamol Metered Dose Inhaler
por: Kale, Ashutosh, et al.
Publicado: (2010)

Formulation and Development of Metered Dose Inhalations of Salbutamol in Solution Form
por: Khale, Anubha, et al.
Publicado: (2011)

Tribo-Charging Behaviour of Inhalable Mannitol Blends with Salbutamol Sulphate
por: Zellnitz, S., et al.
Publicado: (2019)

SERUM BIOMARKERS IN MORTALITY RISK STRATIFICATION IN PATIENTS, HOSPITALIZED WITH COVID-19 PNEUMONIA IN EARLY AND REMOTE PERIOD
por: Zagidullin, Naufal, et al.
Publicado: (2022)

Lack of efficacy of pre bronchoscopy inhaled salbutamol on symptoms and lung functions in patients with pre-existing airway obstruction
por: Mohan, Anant, et al.
Publicado: (2016)

Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis
por: Franke, Jennifer, et al.
Publicado: (2011)

Combined effects of ivabradine with dobutamine or levosimendan in isolated perfused hearts
por: Konrad, D, et al.
Publicado: (2013)

Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)

Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
por: Urbanek, Irmina, et al.
Publicado: (2014)

Ivabradine for junctional ectopic tachycardia in post congenital heart surgery
por: Kumar, Vivek, et al.
Publicado: (2017)

Heart rate manipulation in dilated cardiomyopathy: Assessing the role of Ivabradine
por: Raja, Deep Chandh, et al.
Publicado: (2018)

Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020)

Association of ivabradin use with ventricular arrhythmias in heart failure patients
por: Pay, L, et al.
Publicado: (2023)

Ivabradine in patients with heart failure: a systematic literature review
por: Khan, Zeba M., et al.
Publicado: (2023)

The topical study of inhaled drug (salbutamol) delivery in idiopathic pulmonary fibrosis
por: Usmani, Omar S., et al.
Publicado: (2018)

Safety profile and efficacy of ivabradine in heart failure due to Chagas heart disease: a post hoc analysis of the SHIFT trial
por: Bocchi, Edimar Alcides, et al.
Publicado: (2017)

Ivabradine, the pure heart rate-lowering drug, shown to reduce morbidity and mortality in heart failure
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2cmnpglfpvrtl7ejovbnmqkmq1